Tags: 
Innovation in clinical research is a long-term need due to several factors, including the high failure rate and skyrocketing costs.
Healthcare has been changing rapidly for many years. The COVID-19 pandemic has accelerated by helping drive the shift to value-based healthcare. Instead, the productivity of pharmaceutical development has been declining due to high failure rates in clinical research.
Strategy is valuable in reducing late clinical trial failure. A well-developed and carefully executed strategy helps mitigate risks, optimize trial design and execution, and increase the chances of successful outcomes. A failed trial can harm the credibility by raising concerns about the research methods, the quality of the data, or the reliability of the therapy under investigation.
Early strategy in clinical research is crucial in evaluating the safety, efficacy, and feasibility of novel treatments. Early strategy enables identifying and validating biomarkers, genetic markers, patient stratification strategies, and other predictive factors that can guide clinical research, accelerating the development of targeted new therapies. By identifying promising compounds early on and efficiently evaluating their safety and efficacy, researchers can streamline the development pathway and quickly bring new treatments to patients.
The SCIO method employs strategic approaches and innovative practices to overcome the challenges associated with traditional clinical development. Leveraging artificial intelligence (AI), data analytics, and a deep understanding of regulatory affairs and medical knowledge to streamline processes, enhance patient recruitment and engagement, and optimize trial design and execution. The SCIO method has been evolving alongside advancement with new technologies and cutting-edge scientific concepts. That is why SCIO tackles the challenges of traditional clinical development and transforms itself to meet products’ specific needs.
Specializing in rare disease, Boston Biotech Clinical Research works with biotech, pharmaceutical, device companies and investors to streamline the clinical trial process. Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements.